Accendra Health Inc (ACH)


Accendra Health Inc. is a healthcare company listed on the NYSE under the ticker ACH. Through its subsidiaries, the company provides healthcare solutions in the United States, with operations centered on in-home care and delivery support for diabetes treatment, home respiratory therapy, and obstructive sleep apnea care. Its respiratory offerings include home oxygen and non-invasive ventilation services, along with continuous positive airway pressure and bi-level positive airway pressure devices and related patient support services. Accendra Health also supplies other home medical equipment and patient care product lines, including ostomy, wound care and negative pressure wound therapy, urology, and incontinence-related products and services. The company serves patients and home health agencies. Formerly known as Owens & Minor, Inc., it adopted the Accendra Health name in December 2025 and is based in Glen Allen, Virginia.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-ACH
$3.34
-2.4% Downside
Fair
$4.49
31.3% Upside
Undervalued
Fair
0.0%
July 31, 2026
-2.5x
-0.6x
0.1x
254.3 M
2.094 B
89.5%
73.4%
0.7
288.2%
Valuation • Fair Value

Accendra Health Inc (NYSE-ACH) Fair Value by Valuation Model

Compare the primary fair value estimate for Accendra Health Inc (NYSE-ACH) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$3.34

Estimated downside of 2.4% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$1.64

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$3.91

Comparable-company valuation reference.

Analyst Price Target

$4.49

Analysts imply upside of 31.3%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Accendra Health Inc (NYSE-ACH) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Accendra Health Inc (NYSE-ACH)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

2.716 B

Current operating scale indicator.

Revenue Forecast

2.576 B

Forward revenue estimate.

EBITDA

323.7 M

Current operating profitability reference.

EBITDA Forecast

344.5 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Accendra Health Inc (NYSE-ACH) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Accendra Health Inc (NYSE-ACH)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

3

Weak quality score that deserves closer review.

Beneish M-Score

-3.17

No elevated caution signal from this screen.

Altman Z-Score

0.7

Lower score that deserves closer risk review.

FCF / Net Income

288.2%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Accendra Health Inc (NYSE-ACH). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Accendra Health Inc (NYSE-ACH)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 31, 2026

Days to Earnings

10

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Accendra Health Inc (NYSE-ACH), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Accendra Health Inc (NYSE-ACH) Stock Forecast & Technical Outlook

Review Accendra Health Inc (NYSE-ACH) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Accendra Health Inc (NYSE-ACH) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for Accendra Health Inc (NYSE-ACH) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Accendra Health Inc (NYSE-ACH) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Accendra Health Inc (NYSE-ACH) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Accendra Health Inc (NYSE-ACH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Accendra Health Inc (NYSE-ACH)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Accendra Health Inc (NYSE-ACH) has a Buy consensus, with 2 buy, 2 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 2
Sell 0
FAQ Fast Investor Answers

Accendra Health Inc (NYSE-ACH) Stock FAQ

Quick answers about Accendra Health Inc (NYSE-ACH) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$3.34
Estimated downside 2.4%
Valuation Rating
Overvalued
Estimated downside of 2.4%
Analyst Target
$4.49
Implied upside 31.3%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Accendra Health Inc (NYSE-ACH) is $3.34. This implies an estimated downside of 2.4% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 2.4% versus the current market price.

The available analyst price target for Accendra Health Inc (NYSE-ACH) is $4.49. The analyst target implies estimated upside of 31.3%.

The current financial health read for Accendra Health Inc (NYSE-ACH) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Accendra Health Inc (NYSE-ACH) is July 31, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Accendra Health Inc (NYSE-ACH) is -2.5x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Accendra Health Inc is 254.3 M.

The current enterprise value listed for Accendra Health Inc is 2.094 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Accendra Health Inc is NYSE-ACH, and the stock is listed on NYSE.

Accendra Health Inc (NYSE-ACH) is listed on NYSE.

The current debt-to-total-capital ratio listed for Accendra Health Inc is 89.5%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Accendra Health Inc is 73.4%. Free float helps investors understand how much of the share base is available for public trading.